期刊论文详细信息
| Journal of Translational Medicine | |
| Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays | |
| Poster Presentation | |
| G Fossati1 | |
| [1] New Medicines, UCB, Slough, UK; | |
| 关键词: Infliximab; Etanercept; Adalimumab; Annexin Versus; Peripheral Blood Lymphocyte; | |
| DOI : 10.1186/1479-5876-8-S1-P37 | |
| 来源: Springer | |
 PDF
|
|
【 摘 要 】
【 授权许可】
CC BY
© Nesbitt and Fossati; licensee BioMed Central Ltd. 2010. This article is published under license to BioMed Central Ltd.
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202311103562787ZK.pdf | 139KB |  download |
【 参考文献 】
- [1]
878987797
028-85220240
